Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts

Willems, Laura, Reichelt, Melissa E., Molina, Jose G., Sun, Chun-Xiao, Chunn, Janci L., Ashton, Kevin J., Schnermann, Jurgen, Blackburn, Michael R. and Headrick, John P. (2006) Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts. Cardiovascular Research, 71 1: 79-87. doi:10.1016/j.cardiores.2006.03.006

Author Willems, Laura
Reichelt, Melissa E.
Molina, Jose G.
Sun, Chun-Xiao
Chunn, Janci L.
Ashton, Kevin J.
Schnermann, Jurgen
Blackburn, Michael R.
Headrick, John P.
Title Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts
Journal name Cardiovascular Research   Check publisher's open access policy
ISSN 0008-6363
Publication date 2006-07-01
Year available 2006
Sub-type Article (original research)
DOI 10.1016/j.cardiores.2006.03.006
Open Access Status Not yet assessed
Volume 71
Issue 1
Start page 79
End page 87
Total pages 9
Language eng
Subject 2705 Cardiology and Cardiovascular Medicine
Abstract Objective: Adenosine deaminase (ADA) may be multifunctional, regulating adenosine levels and adenosine receptor (AR) agonism, and potentially modifying AR functionality. Herein we assess effects of ADA (and A1AR) deficiency on AR-mediated responses and ischaemic tolerance. Methods: Normoxic function and responses to 20 or 25 min ischaemia and 45 min reperfusion were studied in isolated hearts from wild-type mice and from mice deficient in ADA and/or A1ARs. Results: Neither ADA or A1AR deficiency significantly modified basal contractility, although ADA deficiency reduced resting heart rate (an effect abrogated by A1AR deficiency). Bradycardia and vasodilation in response to AR agonism (2-chloroadenosine) were unaltered by ADA deficiency, while A1AR deficiency eliminated the heart rate response. Adenosine efflux increased 10- to 20-fold with ADA deficiency (at the expense of inosine). Deletion of ADA improved outcome from 25 min ischaemia, reducing ventricular diastolic pressure (by 45%; 21 ± 4 vs. 38 ± 3 mm Hg) and lactate dehydrogenase (LDH) efflux (by 40%; 0.12 ± 0.01 vs. 0.21 ± 0.02 U/g/min ischaemia), and enhancing pressure development (by 35%; 89 ± 6 vs. 66 ± 5 mm Hg). Similar protection was evident after 20 min ischaemia, and was mimicked by the ADA inhibitor EHNA (5 μM). Deletion of ADA also enhanced tolerance in A1AR deficient hearts, though effects on diastolic pressure were eliminated. Conclusions: Deficiency of ADA does not alter sensitivities of cardiovascular A1 or A2ARs (despite markedly elevated [adenosine]), but significantly improves ischaemic tolerance. Conversely, A1AR deficiency impairs ischaemic tolerance. Effects of ADA deficiency on diastolic pressure appear solely A1AR-dependent while other ARs or processes additionally contribute to improved contractile recovery and reduced cell death.
Keyword Adenosine deaminase
Adenosine receptor
Gene knockout
General physiology
Q-Index Code C1
Q-Index Status Provisional Code
Grant ID AI-43572
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads - Archived
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 19 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 22 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 08 Jul 2016, 19:18:41 EST by System User